PROVIDER PROFILE · NPI 1013251396
Teresa Hong
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
246
Beneficiaries
—
Total drug cost
$966K
Distinct drugs
8
Brand share
100.0%
Top prescribed drugs
Bictegrav/Emtricit/Tenofov Ala84 claims
Emtricitab/Rilpiviri/Tenof Ala37 claims
Darunavir/Cob/Emtri/Tenof Alaf33 claims
Elviteg/Cob/Emtri/Tenof Alafen28 claims
Dolutegravir/Rilpivirine23 claims
QUALITY · MIPS · 2024
Final MIPS score
86.0
Quality
64.5
Cost
72.2
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.46%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$338
Payment records
9
By payment type
Food and Beverage$338
Top paying entities
Food and Beverage$338
CROSS-REFERENCE